Extension Granted for Case Selection Deadline Key Points: In summary, the granted extension offers parties the opportunity to overcome technical obstacles and ensure compliance with the Court’s directives for case selection within the revised timeframe.
Modest Growth Continues in Hair Relaxer MDL Despite a slight uptick compared to the previous month, April marked another period of sluggish growth for the hair relaxer class action MDL. Only 81 new cases were added to the MDL last month, a marginal increase from the 53 cases reported in March. This modest growth contrasts…
Dispute Over Special Master Selection Persists The defendants are contesting the appointment of Professor Maura Grossman as a special master in this case. They argue that her recent collaboration with the defendants’ counsel on confidential matters related to the same issues disqualifies her from the role. Specifically, the defendants highlight Professor Grossman’s close work with…
Developments in Hair Relaxer Lawsuits: Dismissal Rights, Discovery Disputes, and Case Filings As of April 2, 2024, a significant dispute has emerged regarding plaintiffs’ requests to dismiss or amend their lawsuits without prejudice before the defendants respond, a move opposed by the defendants. Both sides accuse each other of obstructing standard Multidistrict Litigation (MDL) procedures….
On March 8, 2024, a status hearing was held in the litigation, addressing several key issues: The next hearing is scheduled for April 11, 2024, at 11:00 a.m.
Hair Relaxer Lawsuits and Litigation Progress As of March 1, more than 8,300 product liability lawsuits have been filed by women alleging injuries such as uterine cancer, ovarian cancer, and fibroids due to exposure to endocrine-disrupting chemicals in hair relaxers like Dark & Lovely, Just for Me, Optimum, and ORS Olive Oil. Emergence of Litigation:…
Chemical Hair Straightener Lawsuits Chemical hair straightener lawsuits have emerged as individuals allege a correlation between these products, notably those manufactured by L’Oréal and other companies, and heightened risks of uterine, endometrial, and ovarian cancers. Here’s a breakdown of key points surrounding these legal actions: Basis of Lawsuits: Profile of Plaintiffs: Marketing Dynamics: Eligibility and…
Allegations against L’Oréal and other manufacturers suggest that chemical hair straightener products may lead to cancer and other health complications. Lawsuits argue that these companies failed to adequately warn consumers about the potential risks, including heightened chances of uterine, endometrial, and ovarian cancer. Current Status of Chemical Hair Straightener Lawsuits As of February 2024, a…
A recent study conducted by Boston University has shed light on a concerning association between the use of chemical hair straighteners and an increased risk of uterine cancer among postmenopausal women. This study, part of the Black Women’s Health Study, tracked 45,000 women without a history of cancer over a span of 22 years, analyzing…
The U.S. Food and Drug Administration (FDA) is considering a ban on formaldehyde in chemical hair straighteners, citing its link to various health risks, including cancer. Currently, the FDA advises against the use of products containing formaldehyde due to potential adverse effects. Formaldehyde, when released into the air during the heating process of hair straightening,…